Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation A review

被引：0

作者：

Manea, Maria ^{[1
]}

Marcu, Dragos ^{[1
,2
]}

Stoian, Anca Pantea ^{[2
]}

Gaman, Mihnea Alexandru ^{[2
]}

Gaman, Amelia Maria ^{[3
]}

Socea, Bogdan ^{[2
,4
]}

Neagu, Tiberiu Paul ^{[2
,5
]}

Stanescu, Ana Maria Alexandra ^{[2
]}

Bratu, Ovidiu Gabriel ^{[1
,2
,6
]}

Diaconu, Camelia Cristina ^{[2
,5
]}

机构：

[1] Carol Davila Univ Emergency Cent Emergency Mil Ho, 88 Mircea Vulcanescu Str, Bucharest 010825, Romania

[2] Univ Med & Pharm Carol Davila, 8 Eroii Sanitari Str, Bucharest 050474, Romania

[3] Univ Med & Pharm Craiova, Filantropia City Hosp, 1 Filantropiei Str, Craiova 200143, Romania

[4] St Pantelimon Clin Emergency Hosp, 340-342 Pantelimon Rd, Bucharest 021659, Romania

[5] Clin Emergency Hosp Bucharest, 8 Calea Floreasca, Bucharest 014461, Romania

[6] Acad Romanian Scientists, 54 Splaiul Independentei, Bucharest 050085, Romania

来源：

REVISTA DE CHIMIE | 2018年 / 69卷 / 11期

关键词：

heart failure; atrial fibrillation; diastolic dysfunction; left atrial enlargerment; QUALITY-OF-LIFE; PROGNOSTIC-SIGNIFICANCE; CATHETER ABLATION; EUROPEAN-SOCIETY; RHYTHM CONTROL; MORTALITY; OUTCOMES; RISK; GUIDELINES; MORBIDITY;

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are two conditions with an increased incidence and prevalence. Numerous studies highlight the pathophysiological links between HFpEF and AF and the common risk factors. Patients with HFpEF have a high incidence of AF. It is difficult to determine which of the pathologies appears first: HFpEF or AF. In HFpEF, left atrium suffers a structural and functional remodelling process, which contributes to the occurrence of AF. Also, AF determines dyastolic dysfunction, the main mechanism for HFpEF development. The diagnosis of HEpEF in the presence of AF is more difficult, because the symptoms of HF resemble those of AF. Also, the presence of AF makes more difficult the correct echo cardiographic evaluation of patients with HF. More research is needed in order to develop new therapies that can improve the prognosis of patients with HFpEF and AF.

引用

页码：4180 / 4184

页数：5

共 62 条

[1] Aging, Metabolic, and Degenerative Disorders: Biomedical Value of Antioxidants [J].

Abdel-Daim, Mohamed M. ;

Zakhary, Nadia I. ;

Aleya, Lotfi ;

Bungau, Simona G. ;

Bohara, Raghvendra A. ;

Siddiqi, Nikhat J. .

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018

[2] A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction [J].

Adabag, Selcuk ;

Rector, Thomas S. ;

Anand, Inder S. ;

McMurray, John J. ;

Zile, Michael ;

Komajda, Michel ;

McKelvie, Robert S. ;

Massie, Barry ;

Carson, Peter E. .

EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (11) :1175-1182

[3] INDEPENDENT RISK-FACTORS FOR ATRIAL-FIBRILLATION IN A POPULATION-BASED COHORT - THE FRAMINGHAM HEART-STUDY [J].

BENJAMIN, EJ ;

LEVY, D ;

VAZIRI, SM ;

DAGOSTINO, RB ;

BELANGER, AJ ;

WOLF, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (11) :840-844

[4] Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation Two Systematic Literature Reviews and Meta-Analyses [J].

Calkins, Hugh ;

Reynolds, Matthew R. ;

Spector, Peter ;

Sondhi, Manu ;

Xu, Yingxin ;

Martin, Amber ;

Williams, Catherine J. ;

Sledge, Isabella .

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (04) :349-U49

[5] Structural and functional remodeling of the left atrium [J].

Casaclang-Verzosa, Grace ;

Gersh, Bernard J. ;

Tsang, Teresa S. M. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) :1-11

[6]

Checherita IA, 2013, ROM J MORPHOL EMBRYO, V54, P539

[7] Effect of an irregular ventricular rhythm on cardiac output [J].

Daoud, EG ;

Weiss, R ;

Bahu, M ;

Knight, BP ;

Bogun, F ;

Goyal, R ;

Harvey, M ;

Strickberger, SA ;

Man, KC ;

Morady, F .

AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (12) :1433-&

[8] Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program [J].

Ducharme, Anique ;

Swedberg, Karl ;

Pfeffer, Marc A. ;

Cohen-Solal, Alain ;

Granger, Christopher B. ;

Maggioni, Aldo P. ;

Michelson, Eric L. ;

McMurray, John J. V. ;

Olsson, Lars ;

Rouleau, Jean L. ;

Young, James B. ;

Olofsson, Bertil ;

Puu, Margareta ;

Yusuf, Salim .

AMERICAN HEART JOURNAL, 2006, 152 (01) :86-92

[9] Heart failure and tachycardia-induced cardiomyopathy [J].

Ellis E.R. ;

Josephson M.E. .

Current Heart Failure Reports, 2013, 10 (4) :296-306

[10] Heart failure with preserved ejection fraction: uncertainties and dilemmas [J].

Ferrari, Roberto ;

Boehm, Michael ;

Cleland, John G. F. ;

Paulus, Walter J. S. ;

Pieske, Burkert ;

Rapezzi, Claudio ;

Tavazzi, Luigi .

EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (07) :665-671

← 1 2 3 4 5 6 7 →